Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Nuclear Medicine

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2967/jnumed.112.107375PMID 23204495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeks.

  2012cited by this paper
• Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival.

  2012cited by this paper
• Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival

  2012cited by this paper
• Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.

  2012cited by this paper
• Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET

  2012cited by this paper
• Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer.

  2012cited by this paper
• 18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study

  2011cited by this paper
• Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

  2011cited by this paper
• Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.

  2011cited by this paper
• Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer

  2011cited by this paper
• Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer

  2011influential reference
• PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer

  2011cited by this paper
• Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker.

  2011cited by this paper
• FDG-PET as a Potential Tool for Selecting Patients with Advanced Non–Small Cell Lung Cancer Who May Be Spared Maintenance Therapy after First-Line Chemotherapy

  2011cited by this paper
• Repeat FDG-PET for predicting pathological tumor response and prognosis after neoadjuvant treatment in nonsmall cell lung cancer: comparison with computed tomography.

  2010cited by this paper
• Phantom study on radiotherapy planning using PET/CT--delineation of GTV by evaluating SUV.

  2010cited by this paper
• Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage

  2010cited by this paper
• Is FDG‐PET suitable for evaluating neoadjuvant therapy in non‐small cell lung cancer? Evidence with systematic review of the literature

  2010cited by this paper
• Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images.

  2009cited by this paper
• Exploring feature-based approaches in PET images for predicting cancer treatment outcomes

  2009cited by this paper
• Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer

  2009cited by this paper
• From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

  2009influential reference
• Coregistered FDG PET/CT-Based Textural Characterization of Head and Neck Cancer for Radiation Treatment Planning

  2009influential reference
• Texture Analysis of Aggressive and Nonaggressive Lung Tumor CE CT Images

  2008cited by this paper
• Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.

  2008cited by this paper
• Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome

  2008cited by this paper
• Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy

  2006cited by this paper
• Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.

  2005cited by this paper
• Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer.

  2005cited by this paper
• Fractal Analysis of Internal and Peripheral Textures of Small Peripheral Bronchogenic Carcinomas in Thin-section Computed Tomography: Comparison of Bronchioloalveolar Cell Carcinomas With Nonbronchioloalveolar Cell Carcinomas

  2003cited by this paper
• Textural features corresponding to textural properties

  1989cited by this paper

• Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography metabolic radiomics in predicting response to chemotherapy in patients with non-small cell lung cancer.

  2026cites this paper
• A prognostic PET radiomic model for risk stratification in non-small cell lung cancer: integrating radiogenomics and clinical features to predict survival and uncover tumor biology insights

  2025influential citation
• Integrated Lesion and Extranodal PET/CT Radiomics for Predicting Treatment Response in Hodgkin Lymphoma

  2025cites this paper
• The 100 most-cited radiomics articles in cancer research: A bibliometric analysis.

  2025cites this paper
• Texture analysis and metabolic parameters of 18F-FDG PET/CT to predict primary tumour response and prognosis of paediatric soft tissue sarcomas

  2025cites this paper
• An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [18F]FDG PET/CT radiomics.

  2025cites this paper
• Practical use of radiomic features as a metric for image quality discrimination in [18F] FDG-PET: a pilot study

  2025cites this paper
• A narrative review of imaging intratumor heterogeneity in non-small cell lung cancer: current advances

  2025cites this paper
• A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC

  2025cites this paper
• Patch-Based Texture Feature Extraction Towards Improved Clinical Task Performance

  2025cites this paper
• Scaling laws for Haralick texture features of linear gradients

  2025cites this paper
• Impact of [18F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role.

  2025cites this paper
• The Value of Baseline [18F]FDG-PET in Predicting the Progression-Free Survival in Patients with Thymic Epithelial Tumours: A Systematic Review and Meta-Analysis

  2025cites this paper
• A narrative review of the prediction of immunotherapy efficacy for treating NSCLC: An artificial intelligence perspective

  2025cites this paper
• A Pilot Study on Quantitative Accuracy and Radiomic Feature Stability of Deep Progressive Learning Reconstruction in NSCLC PET.

  2025cites this paper
• Valor del análisis de la textura radiómica de la masa primaria y el ganglio linfático mediastínico de la PET/TC en la supervivencia de pacientes con cáncer de pulmón de célula no pequeña

  2024cites this paper
• A novel histopathological feature of spatial tumor–stroma distribution predicts lung squamous cell carcinoma prognosis

  2024cites this paper
• A study on the radiomic correlation between CBCT and pCT scans based on modified 3D-RUnet image segmentation

  2024cites this paper
• A Tumor Volume Segmentation Algorithm Based on Radiomics Features in FDG-PET in Lung Cancer Patients, Validated Using Surgical Specimens

  2024cites this paper
• Multicenter PET image harmonization using generative adversarial networks

  2024cites this paper
• Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients

  2024cites this paper
• An 18F‐FDG‐PET/CT‐based radiomics signature for estimating malignance probability of solitary pulmonary nodule

  2024cites this paper
• A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study.

  2024cites this paper
• Hybrid deep spatial and statistical feature fusion for accurate MRI brain tumor classification

  2024cites this paper
• The Value of PET/CT Radiomic Texture Analysis of Primary Mass and Mediastinal Lymph Node on Survival in Patients with Non-Small Cell Lung Cancer.

  2024cites this paper
• Updates in Management of Unresectable Stage III Non Small Cell Lung Cancer: A Radiation Oncology Perspective

  2024cites this paper
• Development and Validation of Prognostic Models Using Radiomic Features from Pre-Treatment Positron Emission Tomography (PET) Images in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients

  2024cites this paper
• Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer

  2023cites this paper
• Role of Textural Analysis of Pretreatment 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Prediction in Esophageal Carcinoma Patients

  2023cites this paper
• Spatial assessments in texture analysis: what the radiologist needs to know

  2023cites this paper
• Reproducibility of the principal component analysis (PCA)‐based data‐driven respiratory gating on texture features in non‑small cell lung cancer patients with 18F‑FDG PET/CT

  2023cites this paper
• A proposed methodology for detecting the malignant potential of pulmonary nodules in sarcoma using computed tomographic imaging and artificial intelligence-based models

  2023cites this paper
• Magnetic resonance imaging in cervical cancer: current opportunities of radiomics analysis and prospects for its further developmen

  2023cites this paper
• Multimodality and temporal analysis of cervical cancer treatment response

  2023cites this paper
• Temporal Stability and Prognostic Power of Radiomic Features for Survival Analysis in Lung Adenocarcinoma

  2023cites this paper
• Bounds for Haralick features in synthetic images with sinusoidal gradients

  2023cites this paper
• 18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer

  2023cites this paper
• Principal Component Analysis Applied to Radiomics Data: Added Value for Separating Benign from Malignant Solitary Pulmonary Nodules

  2023cites this paper
• Heterogeneity of Glycolytic Phenotype Determined by 18F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer

  2023cites this paper
• Exploring Texture Analysis to Optimize Bladder Preservation in Muscle Invasive Bladder Cancer.

  2022cites this paper
• The cassandra paradox: looking into the crystal Ball of radiomics in thoracic surgery

  2022cites this paper
• Combined whole-lesion radiomic and iodine analysis for differentiation of pulmonary tumors

  2022cites this paper
• 18F-FDG PET/CT-based radiomics nomogram could predict bone marrow involvement in pediatric neuroblastoma

  2022cites this paper
• CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment

  2022cites this paper
• Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy

  2022cites this paper
• Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes

  2022cites this paper
• Immunotherapy in unresectable stage III non-small cell lung cancer: state of the art and novel therapeutic approaches.

  2022cites this paper
• Predictive value of clinical and 18F-FDG-PET/CT derived imaging parameters in patients undergoing neoadjuvant chemoradiation for esophageal squamous cell carcinoma

  2022cites this paper
• [18F]FDG-PET/CT radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications.

  2022cites this paper
• Incremental benefits of size-zone matrix-based radiomics features for the prognosis of lung adenocarcinoma: advantage of spatial partitioning on tumor evaluation

  2022cites this paper
• Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer

  2022cites this paper
• Prediction of TACE Treatment Response in a Preoperative MRI via Analysis of Integrating Deep Learning and Radiomics Features

  2022cites this paper
• Radiomics in Oncological PET Imaging: A Systematic Review—Part 1, Supradiaphragmatic Cancers

  2022cites this paper
• Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of 18F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

  2022cites this paper
• Prediction of Oncology Treatment Outcomes

  2022cites this paper
• Heterogeneity derived from 18F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients

  2022cites this paper
• Radiomics in medical imaging: pitfalls and challenges in clinical management

  2022cites this paper
• The Predictive Value of Magnetic Resonance Imaging-based Texture Analysis in Evaluating Histopathological Grades of Breast Phyllodes Tumor

  2022cites this paper
• The value of CT-based radiomics in early assessment of chemotherapeutic effect in patients with advanced lung adenocarcinoma: a preliminary study

  2022cites this paper
• Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on 18F-FDG PET/CT for Patients with Colorectal Cancer

  2022cites this paper
• Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters

  2022cites this paper
• Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma.

  2021cites this paper
• Ultrasonography in the Diagnosis of Adnexal Lesions: The Role of Texture Analysis

  2021cites this paper
• Emerging applications of imaging in glioma: focus on PET/MRI and radiomics

  2021cites this paper
• Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.

  2021cites this paper
• Whole-tumor 3D volumetric MRI-based radiomics approach for distinguishing between benign and malignant soft tissue tumors

  2021cites this paper
• Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma

  2021cites this paper
• PET Radiomic Features Variability: A Phantom Study on the Influence of Reconstruction and Discretization Method

  2021cites this paper
• Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging

  2021cites this paper
• Association of 18F-FDG PET/CT textural features with immunohistochemical characteristics in invasive ductal breast cancer.

  2021cites this paper
• Radiomics as a New Frontier of Imaging for Cancer Prognosis: A Narrative Review

  2021cites this paper
• Fundamentals of Radiomics in Nuclear Medicine and Hybrid Imaging

  2021cites this paper
• Prognostication Based on Texture Analysis of Baseline 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Nonsmall-Cell Lung Carcinoma Patients Who Underwent Platinum-Based Chemotherapy as First-Line Treatment

  2021cites this paper
• CMAR_A_287128 307..317

  2021cites this paper
• Association of 18F-FDG PET/CT textural features with immunohistochemical characteristics in invasive ductal breast cancer.

  2021cites this paper
• Prognostic Value of Computed Tomography and/or 18F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer.

  2021cites this paper
• Methodological aspects and standardization of PET radiomics studies

  2021cites this paper
• Correction to: Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers

  2021cites this paper
• A Phantom Study to Investigate Robustness and Reproducibility of Grey Level Co-Occurrence Matrix (GLCM)-Based Radiomics Features for PET

  2021cites this paper
• Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.

  2021cites this paper
• Stage-Specific PET Radiomic Prediction Model for the Histological Subtype Classification of Non-Small-Cell Lung Cancer

  2021cites this paper
• Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers

  2021cites this paper
• A [68Ga]Ga-DOTANOC PET/CT Radiomic Model for Non-Invasive Prediction of Tumour Grade in Pancreatic Neuroendocrine Tumours

  2021cites this paper
• Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC)

  2021cites this paper
• Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma

  2021cites this paper
• Methodological studies

  2021cites this paper
• Radiomics and Digital Image Texture Analysis in Oncology (Review)

  2021cites this paper
• Texture features of primary tumor on 18F-FDG PET images in non-small cell lung cancer: The relationship between imaging and histopathological parameters.

  2021cites this paper
• Volumetric PET Parameters Predict Prognosis after Definitive Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-Small Cell Lung Cancer.

  2021cites this paper
• A Systematic Review of PET Textural Analysis and Radiomics in Cancer

  2021cites this paper
• A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics

  2020cites this paper
• Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions

  2020cites this paper
• The Emerging Role of Radiomics in COPD and Lung Cancer

  2020cites this paper
• Impact of contouring variability on oncological PET radiomics features in the lung

  2020cites this paper
• 18F-Fluorodeoxyglucose PET in Locally Advanced Non-small Cell Lung Cancer: From Predicting Outcomes to Guiding Therapy.

  2020cites this paper
• Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?

  2020cites this paper
• KRAS/NRAS/BRAF mutation status in patients with liver metastases of colorectal cancer

  2020cites this paper
• CMAR_A_251598 6421..6430

  2020cites this paper
• Radiomics and artificial Intelligence for PET imaging analysis.

  2020cites this paper
• Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma

  2020cites this paper